Brief Report - (2025) Volume 16, Issue 5
Received: 01-Oct-2025, Manuscript No. jtse-26-184774;
Editor assigned: 03-Oct-2025, Pre QC No. P-184774;
Reviewed: 17-Oct-2025, QC No. Q-184774;
Revised: 22-Oct-2025, Manuscript No. R-184774;
Published:
29-Oct-2025
, DOI: 10.37421/2157-7552.2025.16.452
Citation: Haddad, Yara. ”Biodegradable Polymers Revolutionize Tissue Engineering: Tailored Solutions.” J Tissue Sci Eng 16 (2025):452.
Copyright: © 2025 Haddad Y. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution and reproduction in any medium, provided the original author and source are credited.
Biodegradable polymers are at the forefront of revolutionizing tissue engineering, offering scaffolds that effectively mimic the native extracellular matrix and degrade over time. This controlled degradation facilitates cell proliferation and repopulation of defect sites, thereby eliminating the necessity for secondary surgical interventions to remove implants [1].
Current research efforts are intensely focused on precisely tailoring polymer characteristics, including degradation rates, mechanical resilience, and bioactivity, to align with the specific requirements of diverse tissue types. The development of smart polymers, engineered to respond dynamically to physiological cues and to incorporate crucial growth factors, is demonstrating exceptional promise for accelerating and enhancing regenerative processes. Furthermore, the seamless integration of these advanced materials with sophisticated cellular therapies and cutting-edge fabrication methodologies, such as three-dimensional printing, is actively paving the way for highly personalized and remarkably effective solutions within the field of regenerative medicine [1].
In the realm of cartilage tissue engineering, poly(lactic-co-glycolic acid) (PLGA) has emerged as a material of significant interest. Investigations have involved the fabrication of porous PLGA scaffolds, which are then rigorously assessed for their capacity to sustain chondrocyte proliferation and extracellular matrix elaboration, both in vitro and in vivo. The observed outcomes consistently indicate that PLGA scaffolds possess a remarkable ability to effectively promote chondrogenesis, a crucial step in cartilage formation, thereby highlighting their considerable potential for the repair of articular cartilage defects [2].
Injectable hydrogels, particularly those formulated from hyaluronic acid derivatives, are showcasing considerable promise for soft tissue regeneration applications. These advanced hydrogel systems are characterized by their tunable mechanical properties, a critical feature that can be modulated to optimize interaction with cells. They actively promote cell adhesion, a fundamental prerequisite for successful tissue integration, and importantly, guide cell differentiation towards the desired lineage. Experimental studies have yielded highly encouraging results in the regeneration of dermal tissue defects, underscoring the significant therapeutic potential offered by these intelligent biomaterials in addressing a range of soft tissue injuries [3].
The field of neural tissue engineering is witnessing significant advancements through the utilization of electrospun polycaprolactone (PCL) nanofibers. These PCL-based scaffolds are meticulously engineered with the specific objective of guiding axonal outgrowth and actively promoting remyelination, both essential processes for restoring nerve function. Pre-clinical animal studies have provided compelling evidence of substantial functional recovery in models of nerve defects, unequivocally underscoring the remarkable efficacy of nanofibrous PCL materials in the context of neural tissue regeneration and repair [4].
For bone tissue engineering applications, composite scaffolds integrating chitosan and hydroxyapatite are garnering substantial attention. The synergistic interplay between these two components results in a significant enhancement of both mechanical properties, crucial for load-bearing applications, and osteoconductivity, the ability to support bone growth. Comprehensive evaluations, conducted both in vitro and in vivo, have consistently demonstrated a noticeable acceleration in bone formation rates and a marked improvement in the integration of the engineered constructs with the existing native bone tissue, indicating their robustness for skeletal repair [5].
Silk fibroin scaffolds are being explored as a promising avenue for cardiac tissue engineering. As a naturally derived biodegradable polymer, silk fibroin provides an exceptionally suitable microenvironment that fosters cardiomyocyte differentiation and supports their functional maturation. Research in this area has yielded highly encouraging results, pointing towards the potential of these scaffolds in the development of functional cardiac patches that could address a critical need in treating heart disease and injury [6].
The strategic incorporation of growth factors into biodegradable polymer scaffolds represents a pivotal strategy for significantly enhancing the efficacy of tissue regeneration efforts. Current research reviews detail various methodologies for the controlled release of essential factors, such as vascular endothelial growth factor (VEGF) and bone morphogenetic protein-2 (BMP-2), from polymer matrices like PLGA and PCL. These controlled release systems are instrumental in promoting improved vascularization and accelerating bone formation, with a strong emphasis on designing sophisticated delivery platforms for optimized therapeutic outcomes [7].
Novel biodegradable polyesteramides are being introduced as promising materials for fabricating highly flexible and conductive scaffolds specifically designed for neural tissue engineering applications. The newly developed materials have consistently demonstrated excellent biocompatibility, a critical factor for any implantable biomaterial, and actively promote neuronal growth and the formation of intricate neural networks. These findings collectively suggest the emergence of a new and highly promising class of materials poised to revolutionize the repair of damaged nervous tissue, offering hope for conditions previously considered untreatable [8].
Three-dimensional (3D) printing technology is being extensively leveraged with biodegradable polymers to engineer patient-specific scaffolds for a wide array of orthopedic applications. Customized scaffolds, often fabricated from materials such as polycaprolactone (PCL) and polylactic acid (PLLA), undergo rigorous testing to confirm their mechanical integrity and ensure excellent cell compatibility. This patient-specific, 3D printing approach enables precise anatomical replication of bone defects and significantly improves the integration of the scaffold with the surrounding host bone tissue, offering a tailored solution for complex orthopedic reconstructions [9].
The integration of decellularized extracellular matrix (dECM) with biodegradable polymers is being explored as a synergistic approach to advance tissue engineering strategies. This combination capitalizes on the inherent bioactivity of dECM, which provides essential cues for cell behavior, and the tunable properties of synthetic polymers, such as controlled degradation and mechanical strength. Studies have shown enhanced performance in the regeneration of complex tissues, including skin and liver, indicating the significant potential of this hybrid approach for a broad spectrum of regenerative medicine applications [10].
Biodegradable polymers are fundamentally transforming the landscape of tissue engineering by providing advanced scaffold materials that closely mimic the extracellular matrix. A key advantage is their inherent ability to degrade over time, facilitating the natural repopulation of defect sites by cells and thereby obviating the need for a subsequent surgery to remove the implanted material [1].
Significant advancements are being made in precisely engineering polymer properties like degradation rate, mechanical strength, and bioactivity to match the specific demands of different tissue types. Furthermore, the development of smart polymers, which can respond to physiological signals, and the incorporation of potent growth factors are showing exceptional promise for improving regenerative outcomes. The synergistic combination of these advanced materials with cellular therapies and sophisticated fabrication techniques, such as 3D printing, is actively charting a course towards highly personalized and effective solutions in regenerative medicine [1].
The application of poly(lactic-co-glycolic acid) (PLGA) in the critical field of cartilage tissue engineering is being actively explored. Researchers have successfully fabricated porous PLGA scaffolds and subsequently evaluated their capacity to support chondrocyte proliferation and the production of extracellular matrix. These assessments, conducted both in vitro and in vivo, have provided compelling evidence that PLGA scaffolds can indeed effectively promote chondrogenesis, a vital process for cartilage formation, thus underscoring their significant potential for repairing articular cartilage defects [2].
Injectable hydrogels derived from hyaluronic acid derivatives are emerging as a highly promising class of biomaterials for soft tissue regeneration. These hydrogels are characterized by their tunable mechanical properties, allowing for tailored adjustments to match tissue requirements. Crucially, they actively promote cell adhesion, a foundational step for successful integration, and facilitate cell differentiation towards the desired cell types. Studies focusing on dermal tissue defect regeneration have reported particularly promising outcomes, highlighting the therapeutic potential of these advanced smart biomaterials for a variety of soft tissue repair applications [3].
In the domain of nerve regeneration, electrospun polycaprolactone (PCL) nanofibers are playing an increasingly vital role. These PCL scaffolds are intentionally engineered to provide guidance for axonal outgrowth, a critical process for nerve repair, and to actively promote remyelination, which is essential for restoring nerve signal conductivity. Animal studies investigating nerve defect models have demonstrated significant functional recovery, strongly emphasizing the efficacy of these nanofibrous PCL materials for successful neural tissue engineering strategies [4].
For applications in bone tissue engineering, composite scaffolds formed by combining chitosan and hydroxyapatite are showing considerable promise. The inherent synergistic effect derived from this combination leads to a notable enhancement in both the mechanical properties of the scaffold, which is crucial for load-bearing applications, and its osteoconductivity, the ability to support and guide bone growth. Extensive evaluations, performed in both in vitro and in vivo settings, have indicated accelerated bone formation and improved integration with the host bone tissue, signifying their robustness for orthopedic regeneration [5].
Silk fibroin scaffolds are being investigated for their potential in cardiac tissue engineering. As a naturally derived biodegradable polymer, silk fibroin offers a highly suitable microenvironment conducive to cardiomyocyte differentiation and their subsequent functional maturation. Research in this area has yielded encouraging results, suggesting that these scaffolds could be instrumental in the development of functional cardiac patches for the treatment of various cardiac conditions [6].
The strategic incorporation of growth factors into biodegradable polymer scaffolds is recognized as a crucial element for augmenting tissue regeneration capabilities. This review article meticulously examines various approaches for the controlled release of potent factors, such as VEGF and BMP-2, from established polymers like PLGA and PCL. The ultimate goal is to achieve improved vascularization and enhanced bone formation, with a strong emphasis on designing sophisticated delivery systems that ensure optimal therapeutic efficacy [7].
Novel biodegradable polyesteramides have been developed specifically for the fabrication of scaffolds intended for neural tissue engineering. These advanced materials are designed to be both flexible and conductive, properties that are highly desirable for interacting with neural tissues. The developed materials exhibit excellent biocompatibility and demonstrably promote neuronal growth and the formation of functional neural networks. These findings point towards a promising new category of materials for effectively repairing damaged nervous tissue [8].
The application of 3D printing technology using biodegradable polymers is enabling the creation of patient-specific scaffolds for orthopedic applications. These customized scaffolds, frequently fabricated from materials like PCL and PLLA, undergo thorough testing to verify their mechanical integrity and ensure their compatibility with cells. This personalized 3D printing approach facilitates precise anatomical replication of bone defects and leads to superior integration with the host bone, offering a tailored solution for orthopedic reconstruction [9].
This review delves into the progress made in utilizing decellularized extracellular matrix (dECM) in conjunction with biodegradable polymers for tissue engineering purposes. The synergistic combination leverages the inherent bioactivity of dECM, which provides essential biological cues, with the adjustable properties of synthetic polymers, such as controlled degradation and mechanical characteristics. This integrated approach has demonstrated enhanced performance in regenerating complex tissues, including skin and liver, indicating the significant potential of this combined strategy for a wide range of tissue engineering applications [10].
Biodegradable polymers are revolutionizing tissue engineering by creating scaffolds that mimic the extracellular matrix and degrade over time. Recent advancements focus on tailoring polymer properties for specific tissues, incorporating smart polymers and growth factors for enhanced regeneration. Technologies like 3D printing are enabling personalized solutions. Specific polymers like PLGA are used for cartilage repair, hyaluronic acid hydrogels for soft tissue, PCL nanofibers for nerve regeneration, and chitosan-hydroxyapatite composites for bone. Silk fibroin shows promise for cardiac tissue, while controlled release of growth factors from polymers like PLGA and PCL improves regeneration. Polyesteramides are emerging for neural applications, and 3D printing creates patient-specific orthopedic scaffolds. Combining decellularized ECM with biodegradable polymers enhances the regeneration of complex tissues.
None
None
Journal of Tissue Science and Engineering received 807 citations as per Google Scholar report
